These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 23388179)
1. MYBBP1A suppresses breast cancer tumorigenesis by enhancing the p53 dependent anoikis. Akaogi K; Ono W; Hayashi Y; Kishimoto H; Yanagisawa J BMC Cancer; 2013 Feb; 13():65. PubMed ID: 23388179 [TBL] [Abstract][Full Text] [Related]
2. The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruption. Ono W; Hayashi Y; Yokoyama W; Kuroda T; Kishimoto H; Ito I; Kimura K; Akaogi K; Waku T; Yanagisawa J J Biol Chem; 2014 Feb; 289(8):4928-40. PubMed ID: 24375404 [TBL] [Abstract][Full Text] [Related]
3. Nucleolar protein, Myb-binding protein 1A, specifically binds to nonacetylated p53 and efficiently promotes transcriptional activation. Ono W; Akaogi K; Waku T; Kuroda T; Yokoyama W; Hayashi Y; Kimura K; Kishimoto H; Yanagisawa J Biochem Biophys Res Commun; 2013 May; 434(3):659-63. PubMed ID: 23583237 [TBL] [Abstract][Full Text] [Related]
4. Myb-binding protein 1A (MYBBP1A) is essential for early embryonic development, controls cell cycle and mitosis, and acts as a tumor suppressor. Mori S; Bernardi R; Laurent A; Resnati M; Crippa A; Gabrieli A; Keough R; Gonda TJ; Blasi F PLoS One; 2012; 7(10):e39723. PubMed ID: 23056166 [TBL] [Abstract][Full Text] [Related]
5. RNA content in the nucleolus alters p53 acetylation via MYBBP1A. Kuroda T; Murayama A; Katagiri N; Ohta YM; Fujita E; Masumoto H; Ema M; Takahashi S; Kimura K; Yanagisawa J EMBO J; 2011 Mar; 30(6):1054-66. PubMed ID: 21297583 [TBL] [Abstract][Full Text] [Related]
6. Gradual reduction in rRNA transcription triggers p53 acetylation and apoptosis via MYBBP1A. Kumazawa T; Nishimura K; Katagiri N; Hashimoto S; Hayashi Y; Kimura K Sci Rep; 2015 Jun; 5():10854. PubMed ID: 26044764 [TBL] [Abstract][Full Text] [Related]
7. Opposing function of MYBBP1A in proliferation and migration of head and neck squamous cell carcinoma cells. Acuña Sanhueza GA; Faller L; George B; Koffler J; Misetic V; Flechtenmacher C; Dyckhoff G; Plinkert PP; Angel P; Simon C; Hess J BMC Cancer; 2012 Feb; 12():72. PubMed ID: 22339894 [TBL] [Abstract][Full Text] [Related]
8. Novel nucleolar pathway connecting intracellular energy status with p53 activation. Kumazawa T; Nishimura K; Kuroda T; Ono W; Yamaguchi C; Katagiri N; Tsuchiya M; Masumoto H; Nakajima Y; Murayama A; Kimura K; Yanagisawa J J Biol Chem; 2011 Jun; 286(23):20861-9. PubMed ID: 21471221 [TBL] [Abstract][Full Text] [Related]
9. Critical role of the nucleolus in activation of the p53-dependent postmitotic checkpoint. Tsuchiya M; Katagiri N; Kuroda T; Kishimoto H; Nishimura K; Kumazawa T; Iwasaki N; Kimura K; Yanagisawa J Biochem Biophys Res Commun; 2011 Apr; 407(2):378-82. PubMed ID: 21396915 [TBL] [Abstract][Full Text] [Related]
10. Regulation and function of Myb-binding protein 1A (MYBBP1A) in cellular senescence and pathogenesis of head and neck cancer. George B; Horn D; Bayo P; Zaoui K; Flechtenmacher C; Grabe N; Plinkert P; Krizhanovsky V; Hess J Cancer Lett; 2015 Mar; 358(2):191-199. PubMed ID: 25543088 [TBL] [Abstract][Full Text] [Related]
11. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells. Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437 [TBL] [Abstract][Full Text] [Related]
12. Long Noncoding RNA PURPL Suppresses Basal p53 Levels and Promotes Tumorigenicity in Colorectal Cancer. Li XL; Subramanian M; Jones MF; Chaudhary R; Singh DK; Zong X; Gryder B; Sindri S; Mo M; Schetter A; Wen X; Parvathaneni S; Kazandjian D; Jenkins LM; Tang W; Elloumi F; Martindale JL; Huarte M; Zhu Y; Robles AI; Frier SM; Rigo F; Cam M; Ambs S; Sharma S; Harris CC; Dasso M; Prasanth KV; Lal A Cell Rep; 2017 Sep; 20(10):2408-2423. PubMed ID: 28877474 [TBL] [Abstract][Full Text] [Related]
13. Targeting Mybbp1a suppresses HCC progression via inhibiting IGF1/AKT pathway by CpG islands hypo-methylation dependent promotion of IGFBP5. Weng X; Wu J; Lv Z; Peng C; Chen J; Zhang C; He B; Tong R; Hu W; Ding C; Cao L; Chen D; Wu J; Zheng S EBioMedicine; 2019 Jun; 44():225-236. PubMed ID: 31109829 [TBL] [Abstract][Full Text] [Related]
14. p53 Modulates Notch Signaling in MCF-7 Breast Cancer Cells by Associating With the Notch Transcriptional Complex Via MAML1. Yun J; Espinoza I; Pannuti A; Romero D; Martinez L; Caskey M; Stanculescu A; Bocchetta M; Rizzo P; Band V; Band H; Kim HM; Park SK; Kang KW; Avantaggiati ML; Gomez CR; Golde T; Osborne B; Miele L J Cell Physiol; 2015 Dec; 230(12):3115-27. PubMed ID: 26033683 [TBL] [Abstract][Full Text] [Related]
15. Identification of Myb-binding protein 1A (MYBBP1A) as a novel substrate for aurora B kinase. Perrera C; Colombo R; Valsasina B; Carpinelli P; Troiani S; Modugno M; Gianellini L; Cappella P; Isacchi A; Moll J; Rusconi L J Biol Chem; 2010 Apr; 285(16):11775-85. PubMed ID: 20177074 [TBL] [Abstract][Full Text] [Related]
16. S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. Buckley NE; D'Costa Z; Kaminska M; Mullan PB Cell Death Dis; 2014 Feb; 5(2):e1070. PubMed ID: 24556685 [TBL] [Abstract][Full Text] [Related]
17. RNA-binding protein RNPC1: acting as a tumor suppressor in breast cancer. Xue JQ; Xia TS; Liang XQ; Zhou W; Cheng L; Shi L; Wang Y; Ding Q BMC Cancer; 2014 May; 14():322. PubMed ID: 24884756 [TBL] [Abstract][Full Text] [Related]
18. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53. Heminger K; Markey M; Mpagi M; Berberich SJ Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469 [TBL] [Abstract][Full Text] [Related]
19. Myb-binding protein 1a (Mybbp1a) regulates levels and processing of pre-ribosomal RNA. Hochstatter J; Hölzel M; Rohrmoser M; Schermelleh L; Leonhardt H; Keough R; Gonda TJ; Imhof A; Eick D; Längst G; Németh A J Biol Chem; 2012 Jul; 287(29):24365-77. PubMed ID: 22645127 [TBL] [Abstract][Full Text] [Related]
20. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells. Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]